| abstract |
Treatment or suppression of diseases caused by mitochondrial diseases, such as Friedreich ataxia, label hereditary ocular neuropathy, Kearns-Saire syndrome, and mitochondrial myopathy, encephalopathy, lactoacidosis, seizures (MELAS), energy bio in subjects Compositions and methods useful for the modulation of markers are provided. The present invention provides compounds useful for the treatment or suppression of mitochondrial diseases and methods of using such compounds for the modulation of energy biomarkers. The redox activity therapy for the treatment or suppression of mitochondrial diseases and related aspects of the invention is described in more detail herein. [Selection figure] None |